During the past decade, Texas Oncology-Beaumont conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 10 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Oncology-Beaumont" #1 sponsor was "Bristol-Myers Squibb" with 5 trials, followed by "Calithera Biosciences, Inc" with 2 trials sponsored, "Clovis Oncology, Inc." with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Biotheranostics, Inc." with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology-Beaumont" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Academic and Community Cancer Research United" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Texas Oncology-Beaumont" are "Breast Cancer" (4 trials), "Non-Small Cell Lung Cancer" (3 trials), "Multiple Myeloma" (2 trials), "Non-small Cell Lung Cancer" (2 trials) and "Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification" (1 trials). Many other conditions were trialed in "Texas Oncology-Beaumont" in a lesser frequency.

Most popular intervention types in "Texas Oncology-Beaumont" are "Drug" (15 trials), "Biological" (3 trials), "Other" (2 trials), "Radiation" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (5 trials), "Nivolumab" (3 trials), "Paclitaxel" (3 trials), "Cyclophosphamide" (2 trials) and "Doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Texas Oncology-Beaumont" are 14 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Texas Oncology-Beaumont". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Texas Oncology-Beaumont, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Oncology-Beaumont, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".